The endoplasmic reticulum (ER) is the eukaryotic organelle where most secretory proteins are folded for subsequent delivery to their site of action. Proper folding of newly synthesized proteins is monitored by a stringent ER quality control system. This system recognizes misfolded or unassembled proteins and prevents them from reaching their final destination. Instead, they are extracted from the ER, polyubiquitinated and degraded by the cytosolic proteasome. With the identification of novel components and substrates, a more and more complex picture of this process emerges in which distinct pathways target different sets of substrates for destruction. D
Protein maturation in the endoplasmic reticulum (ER)
About 20% of the 30,000 to 40,000 proteins encoded by the human genome are predicted to be secretory proteins [1] . Targeted by a signal sequence, polypeptides enter the secretory pathway via the Sec61 channel in an unfolded state. This heterotrimeric complex forms a pore in the ER membrane and mediates the import of nascent proteins into this compartment [2] . In the ER, a specialized environment controls posttranslational modifications and allows newly imported polypeptides to assume their native structures and to assemble into multimeric complexes. Because solvent exposed, hydrophobic segments present in unfolded or partially folded proteins tend to aggregate, BiP/Kar2p, a member of the Hsp70 family, and other ER-resident chaperones bind to such hydrophobic patches and preserve the folding competence of the nascent chain [3] .
Several enzymatic activities alter the secondary structure of the polypeptide chain during and after import. Peptidylprolyl-isomerase catalyzes the cis-trans isomerization of proline residues, and oxidoreductases, such as protein disulfide isomerase (PDI) and Erp57, control disulfide bond formation between correct pairs of cysteine residues [4, 5] . N-linked glycosylation is one of the most common posttranslational protein modifications. The covalent attachment of hydrophilic oligosaccharides helps to solubilize the nascent protein chain and contributes to the proper folding, assembly and trafficking of proteins. A study of the folding pathway utilized by the Influenza Hemagglutinin protein proposed that N-glycans may be positioned near cysteine residues to prevent the formation of improper disulfide bonds before the correct partner-cysteine has entered the lumen of the ER [6] . The same study suggested that Nglycans may also serve a similar function on a larger scale: to allow the association of distal protein domains, oligosaccharides are attached to the domain that is synthesized first and help to solubilize the N-terminal domain until the C-terminal partner has been translated. N-linked glycans are trimmed by ER-glucosidase I and II, yielding a monoglucosylated oligosaccharide [7] . In mammalian cells all proteins carrying high mannose oligosaccharides are targeted by an elaborate folding cycle that is crucial for protein maturation in the ER [8] . This pathway involves UDPGlc:glycoprotein glucosyltransferase (GT) and two lectins, the membrane bound calnexin (CNX) and its soluble homologue calreticulin (CRT). CNX and CRT bind selectively to monoglucosylated high mannose proteins. This interaction is disrupted upon removal of the remaining glucose moiety by ER-glucosidase II. GT monitors the ER for misfolded proteins and re-glucosylates polypeptides that require further assistance to acquire their native structure. Monoglucosylated proteins re-enter CNX/CRT cycle and it is believed that the repeated binding and release of immature proteins to CNX/CRT promotes the refolding of unstable conformers until they reach their native structure [9, 10] .
Recognition of irreversibly misfolded proteins in the ER
Although protein maturation in the ER is guided by a large number of chaperones, this process is not always successful. Polypeptides can be trapped irreversibly in a malfolded conformation or mutations in the expressed genes may result in structural changes and thus misfolding. Examples are the cystic fibrosis conductance regulator (CFTR) [11, 12] , and mutant forms of plasma a 1 -antitrypsin [13] and tyrosinase [14] . Another source of aberrant proteins is unassembled subunits of hetero-oligomeric complexes like TCRa or CD3y [15, 16] . To maintain homeostasis in the ER, aberrant proteins must be selectively eliminated from the pool of newly synthesized polypeptides that still undergo folding. How is such selective proteolysis achieved without destroying nascent polypeptides before they can fold? What properties distinguish a terminally misfolded protein from a newly synthesized polypeptide that is merely unfolded and has yet to reach its final conformation?
Proteins that are degraded to regulate cellular processes have conserved structural features that are readily recognized by the ubiquitin proteasome system via specific adapters of the E3 ligases. Immature and permanently misfolded proteins are likely to feature similar structural elements such as solvent-exposed hydrophobic patches. If hydrophobic elements serve as the only motif to target proteins for destruction by the proteasome, aberrant and newly synthesized proteins would be destroyed alike. An additional signal is required to target a malfolded protein for degradation. Proteins that have not matured properly after multiple folding attempts are probably trapped irreversibly in an aberrant configuration. Therefore, a molecular clock that limits the time given to a protein to fold properly could provide such additional signal.
ER-mannosidase I acts on glycoproteins regardless of their conformational state. The time-dependent removal of a critical mannose moiety is likely to limit the time that is given to a glycoprotein to acquire its native structure. The observation that inhibition or mutation of ER-mannosidase I impairs the degradation of several misfolded proteins from the ER lends further support to this model [16] [17] [18] [19] [20] . Htm1p/ EDEM is a lectin thought to be specific for the Man8-oligosaccharide structure generated by ER-mannosidase I that is required for the efficient turnover of misfolded glycoproteins [21] [22] [23] . Since Man8 oligosaccharides are also characteristic for many stable ER-resident proteins, this structure alone cannot suffice to promote degradation. Therefore, a bipartite signal might target terminally misfolded ER-proteins for destruction. Since Htm1p and CNX interact via their transmembrane domains in mammalian cells, the concurrent interaction of a substrate with those factors might provide the required signal: proteins that are still arrested in the CNX/CRT cycle after they were processed by ER mannosidase I are considered irreversibly misfolded and therefore degraded [24, 25] .
The ER contains a large number of oxidoreductases that catalyze disulfide bond formation and isomerization. PDI has also a function in ER quality control and serves to unfold certain substrates before they are degraded [26, 27] . The PDI-like protein Erp57p interacts with CNX and CRT [28] . These complexes allow the combined action of disulfide isomerase and chaperone on the same molecule to enhance the efficiency of the folding process. The interaction of ERp57 with CNX might also link the disposal of glycoproteins with improper disulfide bonds to the Htm1p/EDEM pathway.
ER-Golgi shuttling
In cells overexpressing a mutant form of vesicular stomatitis G protein, a fraction of this protein escapes to the Golgi before it is recycled to the ER [29] . Does vesicular trafficking play a general role in ER-quality control? Mutations in Ufe1p, a factor required for membrane fusion, and Sec23p, involved in the formation of COPII-coated vesicles, stabilize misfolded soluble proteins in the lumen of ER while membrane anchored substrates are not affected [30, 31] . A deletion of the putative cargo receptor Erv29p has a similar effect [32] . Erv29p is required for packing proa-factor into COPII coat vesicles and may also recruit other soluble cargo proteins. These results indicate that a functional secretory pathway is a prerequisite for the efficient turnover of misfolded proteins from the ER. Several explanations can account for this observation. The Golgi apparatus may constitute a quality control checkpoint where misfolded proteins are modified with a tag to enhance their degradation. The specific modification of glycans attached to the misfolded protein could provide such a signal, but Golgi resident glycosyltranferases appears not to be involved in the turnover of misfolded ER proteins. Kar2p is involved in the degradation of aberrant, soluble proteins such as a mutant form of carboxypeptidase Y (CPY*). In several ER-Golgi transport mutants, Kar2p does not localize properly to the ER [33] . If retrograde transport is blocked, Kar2p, and other factors that maintain ER homeo-stasis, might leak into the secretory pathway and impair the degradation of CPY*. Ufe1p and Sec23p were identified in a screen for factors required to maintain the proper ER structure [34] . As discussed before, both proteins are involved in vesicle trafficking and required for the efficient degradation of misfolded proteins from the ER. Since mutations in these genes have a profound effect on the structure of the ER, it seems equally likely that the observed effects on protein turnover could be attributed to a general perturbation of the ER and not to specific defects in the ER quality control system.
Ubiquitination at the ER membrane
The identification of the yeast membrane-anchored ubiquitin-conjugating enzyme Ubc6p provided the first evidence that ubiquitination can occur at the cytosolic face of the ER [35] . Subsequently, two independent genetic screens for yeast mutants that stabilize short-lived ER proteins lead to the discovery of the RING-type ubiquitin ligase Hrd1p/Der3p [36] [37] [38] [39] . This ligase is an integral membrane protein with its active site RING-H2-finger motif facing the cytosol, where it works in concert with the ubiquitin conjugating enzymes Ubc7p and Ubc1p [38] [39] [40] . Ubc7p is a soluble factor that is only active when recruited to the ER by the membrane protein Cue1p [41] . Another membrane-spanning E3 enzyme that participates in the degradation of ER proteins is Doa10p [42, 43] . Doa10p also belongs to the group of RING-type E3 enzymes and uses Ubc7p and Ubc6p to ubiquitinate substrate proteins. Both ligases target different substrates for proteolysis, because loss of Doa10p and Hrd1p/Der3p activity causes enhanced stress within the ER when compared to single knock-out strains [42] . Indeed, degradation of CPY* and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (Hmg2p; see below) proceeds predominantly via the Hrd1p/Der3p pathway [44, 45] , whereas the turnover of Ste6-166p and Pma1-D378N, both mutant forms of cell-surface receptor proteins, depends on Doa10p [43, 46, 47] .
In the cytosol the substrate selection of the ubiquitin proteasome system is mediated by the ubiquitin ligases. Some of these E3 enzymes bind interchangeable adapter proteins that recognize their cognate substrate and thus confer the specificity of the degradation apparatus. Integral proteins of the ER membrane that expose cytosolic domains may be directly accessed by the cytosolic E3 ligases. By contrast, ER lumenal proteins must be escorted to the membrane and at least partially transported into the cytosol by additional factors before ubiquitination can take place. Substrate selection occurs independently of the ubiquitin system, which in this case does not confer the specificity of the degradation process. The mechanism that delivers such misfolded substrates from Htm1p/EDEM, PDI or BIP to the E3 ligases for ubiquitination is unknown. As discussed below, the extraction of proteins from the ER to the cytosol most likely occurs via a channel. It is conceivable that Hrd1p/Der3p and Doa10p form a complex with this putative pore to catalyze the ubiquitination of polypeptides during or right after their dislocation. Two additional yeast proteins involved in ER quality control are Hrd3p and Der1p. The integral membrane protein Hrd3p forms a complex with Hrd1p/Der3p [39, 48, 49] . Since the ER-lumenal part of Hrd3p contains tetratricopeptide repeats that are thought to mediate protein-protein interactions, this protein may bind to ER chaperones and facilitate the presentation of their cargo to Hrd1p/Der3p for ubiquitination [48, 49] . Yeast Der1p was isolated in a genetic screen for mutants that abolish CPY* proteolysis [50] . Der1p constitutes an integral membrane protein and appears to be required for the degradation of soluble ER proteins, whereas it is dispensable for the turnover of membrane-bound ones [51, 52] . A distant mammalian homologue of Der1p, termed Derlin-1 (Der1p like protein 1), is involved in the US11-mediated breakdown of MHC class I molecules [53, 54] . Derlin-1 interacts with US11 and with Class I MHC molecules, suggesting that this protein may function in an intermediate step between substrate recognition and ubiquitination.
Dislocation of ER proteins
All components of the ubiquitination machinery identified so far are either cytosolic or located at the cytosolic face of membrane compartments. First indication that the cytosolic ubiquitination machinery is also required for the elimination of malfolded soluble lumenal ER proteins and thus depends on the proteins' retrograde passage of the ER membrane comes from studies of yeast CPY* [44] . This led to the general view that aberrant ER proteins must first be extracted from this compartment to become fully accessible to the proteasome. Currently, little is known about this process. Export occurs most likely via an aqueous channel that allows the transport of proteins through the hydrophobic environment of the ER membrane while providing a tight seal to prevent unspecific leakage of other molecules. A first indication on the nature of this channel came from studies on a mechanism used by the human cytomegalovirus (HCMV). Class I MHC heavy chain molecules carry a single N-linked glycan and serve to display antigenic peptides to cytotoxic T-cells. US2 and US11, two HCMV gene products, interfere with this antigen presentation pathway by dislocating heavy chain molecules from the ER into the cytosol, where they are destroyed by the proteasome. Inhibition of proteasomal activity in US2 or US11-expressing cells causes the accumulation of deglycosylated heavy chain species in the cytosol [55] . The deglycosylation of the MHC molecules is catalyzed by the cytosolic PNGase1, which indicates that these species represent a degradation intermediate. In pulse chase experiments, deglycosylated heavy chain molecules were coimmunoprecipitated with Sec61 h, a central subunit of the protein import machinery into the ER [56] . This observation suggested that the Sec61 complex can also mediate the export of proteins from the ER. Further evidence for such a function came from work in yeast: certain mutations within components of the yeast Sec61 complex caused a significant delay in the degradation of CPY* and other ERAD substrates, while protein import was affected only to a minor degree [51, 57, 58] . In addition, a genetic interaction between Hrd3p, Hrd1/Der3p and Sec61p was unraveled [48] . Furthermore, an in vitro reconstituted Sec61 complex displayed a pore size that was large enough to allow the passage of molecules that correspond in size to even partially folded proteins [59] . If the Sec61 complex itself constitutes a passive conduit, accessory factors should regulate specificity and directionality of this pore and thus allow protein import and export via the same channel.
A new dislocation channel?
It remains to be determined to what extent the Sec61 complex is involved in the dislocation of proteins from the ER. Genetic evidence indicates that yeast Ubc6p, an integral short-lived protein of the ER membrane, is extracted from the ER independent of Sec61p [60] . Data obtained from the crystallization of the bacterial SecYEG protein-conducting channel, which is highly homologous to the eukaryotic Sec61 protein complex, revealed that this pore most likely allows only the passage of strictly unfolded polypeptide chains [61] . Still, ubiquitinated and glycosylated species of CPY* are detectable in the yeast cytoplasm [44, 62] , and glycosylated Class I MHC molecules can be found in the cytosol of US2-expressing cells when the cytosolic PNGase1 is down-regulated by siRNA [63] . Therefore, glycoproteins must be exported through the ER membrane with their bulky sugar moieties attached. Whether proteins exit the ER in an unfolded state is still an open question. PDI may serve to unfold certain substrates before they are exported, but tightly folded protein domains such as Green Fluorescent Protein or Dihydrofolate reductase fused to the ER-lumenal part of Class I MHC molecules do not impair the turnover of these constructs in cells expressing US2 or US11 [64, 65] . As a consequence, the export channel should be capable to transport large, at least partly folded, glycoproteins. Based on the structure of the closed channel, it has been postulated that the SecYEG channel is gated by an intrinsic structural change that is triggered from the cytoplasmic side of the ER membrane [61] . Such a mechanism would make the Sec61-mediated export of proteins from the ER impossible.
Derlin-1 is found in association with US11 and with both glycosylated and deglycosylated forms of the Class I MHC molecules. This observation indicates that Derlin-1 interacts with heavy chains prior to and after their dislocation. Because Derlin-1, like Der1p, is predicted to contain 4 trans-membrane segments and appears to at least indirectly associate with VCP/p97 (see later), it was proposed that Derlin-1 constitutes a pore for protein export [53] . However, clear evidence for such a function is missing. It is unlikely that this protein plays a general role in substrate dislocation from the ER because US2-mediated MHC-class I turnover does not seem to rely on Derlin-1 function [54] .
Directionality of dislocation
Transport of polypeptides across a membrane requires energy, which provides the directionality of this process. During co-translational protein import the translating ribosomes force nascent chains into the ER. Posttranslational import is driven by the ER resident chaperone BiP, which associates with nascent polypeptides in the ER lumen and undergoes ATP-dependant conformational changes to facilitate protein import [2] . Protein dislocation from the ER depends on energy as well [66] , although the mechanism mediating this process has not been characterized so far. Yeast mutants that attenuate the proteolytic activity of the proteasome accumulate membrane-bound degradation intermediates of several ER proteins, indicating that the proteasome is required for their extraction from the ER [45, 60, 67] . Moreover, inhibition of proteasomal proteolysis impairs export of a number of misfolded substrates from the ER in mammalian cells [16, 68] and can even rescue cellsurface expression of some polypeptides [69, 70] . These observations suggest that dislocation and degradation of ER proteins are coupled processes. Since the 19S cap of the proteasome harbors an AAA-ATPase activity, this complex may contribute to the driving force that removes polypeptides from the ER [71] . Indeed, purified 19S cap particles were able to extract a protein from the ER in ATP-dependant manner in vitro [72] . The notion that the membrane bound yeast transcription factor Spt23p is processed by the proteasome further demonstrates that this protease can interact directly with membrane bound substrates [73] .
Function of VCP/p97/Cdc48p in ER protein degradation
Inhibition of the proteasome has no discernible effect on the extraction kinetics in US11-mediated turnover of class I MHC heavy chains [55, 74] . Yeast CPY* is also exported from the ER independently of proteasomal function [62] . In these cases, a different activity must translocate the substrates across the membrane. Recently, a cytosolic complex containing the AAA-ATPase Cdc48p (or VCP/p97 in mammals) has been shown to participate in the degradation of proteins from the ER [62, [75] [76] [77] [78] . Cdc48p can partake in the formation of two distinct complexes: In concert with p47, Cdc48p is involved in vesicle fusion [79] , whereas a complex of Cdc48p with Ufd1p and Npl4p has a high affinity for ubiquitinated proteins and is involved in proteasomal proteolysis [80] [81] [82] .
There are at least two possibilities how Cdc48p
Ufd1-Npl4 may function in ER protein degradation: Cdc48p
Ufd1-Npl4 activity could provide the energy required to extract proteins from the ER membrane. Alternatively, protein dislocation might occur independent from Cdc48p Ufd1-Npl4 function. In this scenario, Cdc48p
Ufd1-Npl4 could liberate already dislocated polypeptides from the ER membrane, keep them in a soluble state and deliver them to the proteasome. In yeast, the activation of the membrane-bound transcription factor Spt23p requires proteasomal processing and the subsequent release of the active transcription factor from its partner subunit by Cdc48p
Ufd1-Npl4 [83] . This process depends on mono-ubiquitination of the substrate. In a similar mode of action, Cdc48p
Ufd1-Npl4 could mobilize dislocated substrate proteins from the cytosolic face of the ER membrane and hand them over to the proteasome. Interestingly, polyubiquitination is a prerequisite for the dislocation reaction [36, 41, 62, 74, [84] [85] [86] . It appears that the ubiquitin residues on these substrates are not only required for efficient recognition by 26S proteasomes, but serve as a binding site for additional factors like Cdc48p
Ufd1-Npl4 [87] . Since many substrate proteins in the ER contain membrane-spanning regions, Cdc48p
Ufd1-Npl4 may also solubilize such hydrophobic segments in the cytosol. Yeast cells expressing mutant forms of Ufd1p or Npl4p accumulate polyubiquitinated polypeptides that are still membrane-attached [62, 76] . Moreover, class I MHC molecules are stabilized in the ER in vitro, when Cdc48p function is perturbed, indicating that their membrane extraction is abolished [75] . Since Cdc48p also binds to proteins that are not ubiquitinated [82] , the Cdc48p
Ufd1-Npl4 complex may serve a dual role at the ER: it may interact with non-ubiquitinated substrates very early during dislocation, contribute to their extraction from the membrane and facilitate their ubiquitination by ER-resident E3 enzymes. Subsequently, it may bind to the polyubiquitinated substrates with higher affinity, release them from the membrane and keep them in a degradation-competent conformation [82, 88] .
Two cytosolic factors are also involved in the efficient turnover of CPY*. Rad23p and Dsk2p contain a ubiquitinassociated (UBA) domain that recognizes polyubiquitin chains and a ubiquitin-like (UBL) motif that binds to the 19S cap of the proteasome [89] [90] [91] . Yeast mutants that lack both proteins accumulate CPY* in a polyubiquitinated and partly soluble form, suggesting that the dislocation of these molecules has occurred at least in part [92] . Thus, Rad23p and Disk2p may transfer dislocated ER-proteins from the Cdc48p
Ufd1-Npl4 complex to the proteasome for degradation.
CFTR-quality control of ER proteins in the cytoplasm?
One of the first integral membrane proteins demonstrated to be a substrate of the proteasome was a mutant form of the cystic fibrosis conductance regulator (CFTR). This polytopic membrane protein constitutes a chloride channel that is expressed at the apical surface of polarized epithelial cells. Folding and maturation of CFTR is rather inefficient: only a small portion of the synthesized protein is delivered to the plasma membrane, whereas the vast majority is retained in the ER and degraded. Mutations in CFTR that further abrogate this folding process cause the recessively inherited ailment cystic fibrosis. Most patients that suffer from this disease bear the CFTRDF508 allele, which is completely unable to fold correctly and is therefore degraded by the proteasome [11, 12] .
During its maturation in the ER, CFTR binds to CNX via its N-linked glycans. Furthermore, expression of CFTR in a Dhtm1 mutant of yeast shows lectin dependence of degradation, which can be complemented by the mammalian Htm1p orthologue EDEM [93] . However, immature CFTR was also detected in association with the cytosolic Hsp90, indicating that cytosolic factors contribute to the folding of this molecule. Inhibition of this interaction accelerates CFTR turnover [94] . Interestingly, CFTR degradation requires the action of the cytosolic ubiquitin ligase CHIP [95] . Moreover, a negative regulator of CHIP termed HspBP1 also affects CFTR proteolysis [96] . It appears that the structural fitness of CFTR molecules is not only monitored at the lumenal side, but also at the cytoplasmic surface of the ER.
Destruction of secretory proteins by viruses
Some viruses use the ER protein degradation system to promote the proteolytic breakdown of host proteins. As mentioned above, US2 and US11 bind to newly synthesized class I MHC molecules in the ER and trigger their proteasomal destruction [55] . Likewise, the expression of the HIV Vpu protein retains the cell-surface protein CD4 in the ER and results in the subsequent destruction of CD4 by the proteasome [69, 97] . The virally induced degradation of host proteins resembles the turnover of ER quality control substrates where target proteins are also removed from the ER and destroyed by cytosolic 26 S proteasomes. At least US11-mediated protein turnover requires the function of a cellular component that appears to be also involved in the removal of aberrant ER proteins [53, 54] .
A recent study suggests that Vpu-mediated CD4 degradation acts independently of the cellular system to remove aberrant ER proteins [98] . Moreover, this work indicates mechanistic differences between both pathways. In a reconstituted yeast system, heterologously expressed CD4 is degraded by two independent pathways: if CD4 is expressed alone, it is recognized by the quality control system and removed from the ER by a Hrd1p/Ubc7p dependent pathway [98] . Co-expression of Vpu and the FBox protein h-TrCP with CD4 causes turnover of CD4 even in the absence of essential components of the Hrd1p/Ubc7p pathway. This system resembles the situation in virus-infected cells where VPU-mediated degradation of CD4 requires h-TrCP and the ubiquitin ligase SCF. The constitutive ER quality control pathway is capable to degrade mutant forms of CD4 that lack all cytosolically exposed lysine residues, indicating that dislocation is initiated before ubiquitination can occur. By contrast, proteolysis via the Vpu/h-TrCP dependent pathway relies on the presence of the cytosolically exposed lysine residues in CD4. These residues are not required for the interaction with either Vpu or h-TrCP. It appears that during Vpumediated turnover CD4 is first polyubiquitinated at lysine residues exposed to the cytosol and afterwards extracted from the membrane.
Regulated protein degradation at the ER
Since the ER harbors a system that constitutively degrades aberrant proteins, this pathway could also be employed for the specific degradation of properly folded enzymes to regulate their activity. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR) is an integral ER membrane protein that catalyzes the rate limiting step in the mevalonate pathway [99] . The stability of HMGR is linked to the cellular level of farnesyl pyrophosphate (FPP), an intermediate of the mevalonate pathway. At low levels of FPP, HMGR is a stable enzyme, but when FPP is abundant, HMGR becomes short-lived.
A genetic analysis in yeast identified several components of the ER quality control such as Hrd1p/Der3p and Ubc7p to be required for Hmg2p degradation, the yeast orthologue to the mammalian HMGR [36, 100, 101] . Since ER quality control and Hmg2p turnover utilize the same components, these two pathways must join at some point. What are the mechanisms that regulate the entry of a properly folded protein into a pathway that serves the selective removal of misfolded proteins? Abundant levels of FPP, the feedback regulator for Hmg2p, might trigger a reversible structural change within Hmg2p and thus convert the molecule into a substrate of the ER quality control. Consistent with this model, it is possible to visualize such changes by limited proteolysis. Conditions that trigger the degradation of Hmg2p in vivo result in an increased susceptibility of this molecule to exogenously added protease, whereas reduction of cellular FPP levels renders Hmg2p more resistant [102] . Hmg2p turnover and protease sensitivity can also be diminished by glycerol, a dchemical chaperoneT that stabilizes aberrant proteins.
AB-type toxins
Certain pathogenic bacteria produce toxins that consist of two components: The A subunit, which constitutes the active part, and the B subunit, which mediates entry into the target cell [103, 104] . These toxins enter the cell by endocytosis and are transported through the secretory pathway until they reach the ER. Subsequently, only the A subunit is dislocated into the cytosol. In the case of the cholera toxin, three factors involved in ER quality control are required for this step: First, PDI dissociates the A from the B subunit. Next, oxidation of PDI by Ero1 releases the A subunit from PDI. The free A subunit is then translocated to the cytosol probably via the Sec61p channel [105, 106] . While the dislocation of aberrant proteins from the ER requires ubiquitination, the toxin can enter the cytosol independent of this modification [107] . This ubiquitin-independent transport allows the A subunit to evade proteasomal degradation and to execute its function in the cytosol. How dislocation can occur in the absence of ubiquitination is unknown. Thus, the A subunit of the cholera toxin seems to harness elements of ER degradation pathway but it requires an unusual dislocation step to enter the cytosol.
Conclusion
Our knowledge on the proteasomal degradation of ER proteins is still rather limited and the function of many components involved in this process remains to be determined. It seems obvious that the ubiquitin proteasome system accounts for most of the proteolytic activity observed at the ER. Still, it remains unclear why so many different components of the ubiquitin proteasome system are involved. In the turnover of aberrant ER proteins, the substrate selection function of the ubiquitin ligases should play a minor role because this step takes place before dislocation into the cytosol has occurred. Even more puzzling is the fact that several parallel pathways appear to exist that are capable of extracting proteins from the ER and delivering them to the proteasome for destruction. Given the complexity of the system and the medical importance of this process, the detailed study of ERAD will remain an interesting topic for the next years.
